UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000016094 |
|---|---|
| Receipt number | R000018691 |
| Scientific Title | A phase I study of alternate-day administration of S-1 plus leucovorin with bevacizumab in patients with refractory metastatic colorectal cancer. |
| Date of disclosure of the study information | 2014/12/31 |
| Last modified on | 2023/01/10 19:16:34 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/12/31 16:59:13 | ||
| 2 | Update | 2022/07/06 09:13:56 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Organization Organization Address Address Tel |
|
| 3 | Update | 2023/01/10 19:16:34 | Recruitment status Date of IRB Last follow-up date |
